Published in Gut on February 01, 1988
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut (2002) 2.13
Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut (1994) 2.12
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol (2012) 1.63
Cancer surveillance in ulcerative colitis--a time for reappraisal. Gut (1994) 1.56
Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis (2009) 1.53
Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis. Gut (1992) 1.38
Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol (2011) 1.35
Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut (1990) 1.26
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut (1998) 1.26
Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer (2003) 1.25
Crohn's disease and colorectal cancer. Gut (1994) 1.22
Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut (1994) 1.22
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19
Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden. Int J Colorectal Dis (1995) 1.18
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol (2013) 1.17
Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut (1991) 1.16
Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer. Gut (2005) 1.15
Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut (1991) 1.15
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma. Environ Health Perspect (1991) 1.07
Infection, inflammation, and gastrointestinal cancer. Gut (2005) 1.07
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut (2004) 0.98
Ulcerative colitis-associated colorectal cancer. World J Gastroenterol (2014) 0.97
Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol (2012) 0.95
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res (2014) 0.93
Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass. Gut (1989) 0.92
A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut (2000) 0.90
Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis (2006) 0.88
Screening and surveillance for asymptomatic colorectal cancer in IBD. Gut (2003) 0.88
Colon carcinoma in the adolescent. Pediatr Surg Int (1997) 0.86
Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg (2005) 0.86
Techniques for targeting screening in ulcerative colitis. Postgrad Med J (2007) 0.86
Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. BMC Med Genet (2007) 0.85
Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. Am J Pathol (1996) 0.85
Faecal bile acid excretion in children with inflammatory bowel disease. Gut (1991) 0.84
Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol (1998) 0.83
Dysplasia in ulcerative colitis--clinical consequences? Langenbecks Arch Surg (2004) 0.81
Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol (2007) 0.81
Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut (1991) 0.81
DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study. Gut (1992) 0.80
Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients. World J Surg (2013) 0.80
Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis. J Gastroenterol (1997) 0.79
Screening for gastrointestinal cancer: an epidemiological review. Gut (1991) 0.79
Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1991) 0.79
Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol (2016) 0.78
Diagnostic value of DNA image cytometry in ulcerative colitis. Dig Dis Sci (2001) 0.78
p53 mutation in patients with ulcerative colitis in rectal biopsy. Korean J Intern Med (1998) 0.78
Targeting mucosal healing in Crohn's disease. Gastroenterol Hepatol (N Y) (2011) 0.78
Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol (2013) 0.78
Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.78
Surveillance for colitis-associated colon neoplasia. World J Gastroenterol (2010) 0.77
Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis. Gut (1994) 0.76
Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions. Surg Today (2013) 0.76
Colorectal cancer in UC. Gut (1988) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Newly Diagnosed Colonic Adenocarcinoma: The Presenting Sign in a Young Woman with Undiagnosed Crohn's Disease in the Absence of Primary Sclerosing Cholangitis and a Normal Microsatellite Instability Profile. Case Rep Pathol (2017) 0.75
Ulcerative colitis: the fate of the retained rectum. Clin Colon Rectal Surg (2004) 0.75
Screening for colorectal cancer in ulcerative colitis. Gut (1991) 0.75
Does the prognosis of colorectal cancer vary with tumor site? Gastroenterol Hepatol Bed Bench (2011) 0.75
Inflammatory Bowel Disease Associated Colorectal Neoplasia. J Gastrointest Dig Syst (2012) 0.75
The British Society of Gastroenterology Diamond Jubilee. March 1997. Gut (1997) 0.75
A genetic predisposition for colorectal cancer in inflammatory bowel disease. Gut (1988) 0.75
Inflammatory bowel disease associated neoplasia: A surgeon's perspective. World J Gastroenterol (2016) 0.75
AOM/DSS Model of Colitis-Associated Cancer. Methods Mol Biol (2016) 0.75
Screening for colorectal cancer. Ulster Med J (1997) 0.75
Colonoscopic surveillance in ulcerative colitis. Gut (1994) 0.75
Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer. Fam Cancer (2004) 0.75
Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol (2007) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut (1964) 8.63
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut (1963) 6.34
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut (1965) 5.25
Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J (1966) 4.27
Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med (1971) 3.10
Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen. Gut (1985) 2.72
Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet (1983) 2.67
Cancer risk in extensive ulcerative colitis. Ann Surg (1978) 2.40
Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology (1983) 2.37
Ulcerative colitis in the United States Army in 1944. Follow-up with particular reference to mortality in cases and controls. Gut (1963) 2.07
A study of ulcerative colitis in New Zealand, showing a low incidence in Maoris. Br Med J (1962) 2.02
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Cancer morbidity in ulcerative colitis. Gut (1982) 1.82
Long-term prognosis of ulcerative colitis. Br Med J (1966) 1.77
The prognosis of ulcerative colitis. Scand J Gastroenterol (1974) 1.74
Ileostomy and excisional surgery for chronic inflammatory disease of the colon: a survey of one hospital region. Gut (1971) 1.69
Survival rate in Crohn's disease and ulcerative colitis. Scand J Gastroenterol (1979) 1.56
Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology (1983) 1.55
Ulcerative colitis in the Jewish population of Tel-Aviv Jafo. I. Epidemiology. Gastroenterology (1974) 1.50
A practical approach to the risk of cancer in inflammatory bowel disease. Med Clin North Am (1980) 1.46
An epidemiological study of ulcerative colitis in Copenhagen County. Scand J Gastroenterol (1968) 1.32
An experience of ulcerative colitis. 3. Long term outcome. Gastroenterology (1970) 1.13
Ulcerative colitis in Finland. II. One-year incidence in all hospitals. Dis Colon Rectum (1971) 1.10
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature (1999) 8.50
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Yeast cells lacking 5'-->3' exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5' cap structure. Mol Cell Biol (1993) 6.36
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Malignancy in coeliac disease--effect of a gluten free diet. Gut (1989) 5.58
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ (1995) 4.83
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
A simple clinical colitis activity index. Gut (1998) 4.35
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Monitoring clinical trials--interim data should be publicly available. BMJ (2001) 4.20
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy. JAMA (1998) 3.94
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
Breast screening programme: should the interval between tests depend on age? Lancet (1997) 3.36
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
Coeliac disease, gluten-free diet, and malignancy. Gut (1976) 3.15
Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci U S A (2005) 3.05
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
Course and prognosis of Crohn's disease. Gut (1976) 3.02
Pyoderma gangrenosum and its treatment. Lancet (1997) 2.83
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
New small polypeptides associated with DNA-dependent RNA polymerase of Escherichia coli after infection with bacteriophage T4. Proc Natl Acad Sci U S A (1972) 2.75
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology (1996) 2.74
Purification and characterization of a Saccharomyces cerevisiae exoribonuclease which yields 5'-mononucleotides by a 5' leads to 3' mode of hydrolysis. J Biol Chem (1980) 2.71
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Gastric ulcer and gastritis. Gut (1971) 2.58
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Disruption of the gene XRN1, coding for a 5'----3' exoribonuclease, restricts yeast cell growth. Gene (1990) 2.33
Malignancy in Crohn's disease. Gut (1980) 2.33
A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord (2002) 2.29
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol (2000) 2.21
An essential yeast gene with homology to the exonuclease-encoding XRN1/KEM1 gene also encodes a protein with exoribonuclease activity. Mol Cell Biol (1993) 2.20
Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes. EMBO J (1997) 2.18
Prospective health impact assessment: pitfalls, problems, and possible ways forward. BMJ (2001) 2.15
Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut (1994) 2.12
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut (1979) 2.08
Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut (1989) 2.06
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
A tale of seven surgeons. BMJ (2001) 2.03
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart (2008) 2.03
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut (2002) 2.00
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99
The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol (1979) 1.98
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Mortality in Crohn's disease. Gastroenterology (1981) 1.95
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl (1979) 1.94
Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA. EMBO J (1987) 1.93
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg (2000) 1.92
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
The genetics of inflammatory bowel disease. Gut (1997) 1.83
Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to human DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p. Mol Cell Biol (2000) 1.82
Cancer morbidity in ulcerative colitis. Gut (1982) 1.82
The association of autoimmune disorders with inflammatory bowel disease. Q J Med (1989) 1.80
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Crohn's disease and cancer: a population-based cohort study. Gastroenterology (1994) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76
Impact of change to early diagnosis and surgery in major upper gastrointestinal bleeding. Lancet (1975) 1.74
Health care needs assessment in prisons: a toolkit. J Public Health Med (2001) 1.73
Perianal Crohn's disease. Br J Surg (2004) 1.73
Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol (1991) 1.71